Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
- Author(s)
- Minson, A; Tam, C; Dickinson, M; Seymour, JF;
- Details
- Publication Year 2022-03-01,Volume 14,Issue #5,Page 1276
- Journal Title
- Cancers
- Publication Type
- Review
- Abstract
- Targeted therapies continue to change the landscape of lymphoma treatment, resulting in improved therapy options and patient outcomes. Numerous agents are now approved for use in the indolent lymphomas and many others under development demonstrate significant promise. In this article, we review the landscape of targeted agents that apply to the indolent lymphomas, predominantly follicular lymphoma, lymphoplasmacytic lymphoma/Waldenstrom macroglobulinaemia and marginal zone lymphoma. The review covers small molecule inhibitors, immunomodulators and targeted immunotherapies, as well as presenting emerging and promising combination therapies.
- Publisher
- MDPI
- Keywords
- immunotherapy; non-Hodgkin lymphoma; personalised medicine; targeted therapy
- Department(s)
- Haematology
- PubMed ID
- 35267584
- Publisher's Version
- https://doi.org/10.3390/cancers14051276
- Open Access at Publisher's Site
https://doi.org/10.3390/cancers14051276- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-02-07 03:35:29
Last Modified: 2025-02-07 03:38:02